{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:53:05Z","timestamp":1791114785711,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/bor.0b013e32833f1075","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T08:22:19Z","timestamp":1283588539000},"page":"627-632","source":"Crossref","is-referenced-by-count":86,"title":["Malignancy and myositis: novel autoantibodies and new insights"],"prefix":"10.1097","volume":"22","author":[{"given":"Albert","family":"Selva-O'Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M","family":"Grau-Junyent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Labrador-Horrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br J Dermatol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J Rheumatol"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.2009.03216.x","article-title":"Defining cancer risk in dermatomyositis. Part I","volume":"34","author":"Madan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/art.10435","article-title":"The neural network as a predictor of cancer in patients with inflammatory myopathies","volume":"46","author":"Selva-O'Callaghan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R9-3-20210128","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andras","year":"2008","journal-title":"J Rheumatol"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case\u2013control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.semarthrit.2008.09.003","article-title":"Nailfold capillary microscopy in adults with inflammatory myopathy","volume":"39","author":"Selva-O'Callaghan","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the antisynthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/rheumatology\/keg473","article-title":"Jo-1 syndrome with associated poorly differentiated adenocarcinoma","volume":"43","author":"Watkins","year":"2004","journal-title":"Rheumatology"},{"key":"R14-3-20210128","first-page":"169","article-title":"Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome","volume":"35","author":"Legault","year":"2008","journal-title":"J Rheumatol"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archdermatol.2009.152","article-title":"Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm","volume":"145","author":"Fardet","year":"2009","journal-title":"Arch Dermatol"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/art.1780381006","article-title":"The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation","volume":"38","author":"Seelig","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","article-title":"The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities","volume":"95","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2008.169375","article-title":"Evaluation and treatment of inflammatory myopathies","volume":"80","author":"Amato","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: a further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2007.09.004","article-title":"Targeting the neural cell adhesion molecule in cancer","volume":"258","author":"Jensen","year":"2007","journal-title":"Cancer Lett"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine versus extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2230.2009.03227.x","article-title":"Defining cancer risk in dermatomyositis. Part II: assessing diagnostic usefulness of myositis serology","volume":"34","author":"Madan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R27-3-20210128","first-page":"S518","article-title":"Autoantibodies to transcriptional intermediary factor-1 gamma (TIF-1\u03b3) in dermatomyositis [abstract]","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.onc.1202655","article-title":"TIF1\u03b3, a novel member of the transcriptional intermediary factor 1 family","volume":"18","author":"Venturini","year":"1999","journal-title":"Oncogene"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"e1000575","DOI":"10.1371\/journal.pgen.1000575","article-title":"Inactivation of TIF1\u03b3 cooperates with KrasG12D to induce cystic tumors of the pancreas","volume":"5","author":"Vincent","year":"2009","journal-title":"PLoS Genet"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009740802687455","article-title":"Association of distinct clinical subsets with myositis-specific autoantibodies towards anti155\/140-kDa polypeptides, anti140-kD polypeptides, and antiaminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study","volume":"38","author":"Fujikawa","year":"2009","journal-title":"Scan J Rheumatol"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","article-title":"Cancer-associated myositis and antip155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy","volume":"89","author":"Trallero-Aragu\u00e1s","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","article-title":"Positron emission tomography-computed tomography in paraneoplastic neurological disorders. Systematic analysis and review","volume":"67","author":"McKeon","year":"2010","journal-title":"Arch Neurol"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jbspin.2007.12.002","article-title":"18Fluorine fluorodeoxyglucose-positron emission tomography\/computed tomography in dermatomyositis","volume":"75","author":"Kim","year":"2008","journal-title":"Joint Bone Spine"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.rlu.0000257282.76269.85","article-title":"F-18 FDG PET\/CT detection of mediastinal malignancy in a patient with dermatomyositis","volume":"32","author":"Liau","year":"2007","journal-title":"Clin Nucl Med"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1468-3083.2007.02220.x","article-title":"The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis","volume":"21","author":"Munoz","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus positron emission tomography\/computed tomography in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic esclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaut.2009.12.006","article-title":"Epigenetics and autoimmunity","volume":"34","author":"Brooks","year":"2010","journal-title":"J Autoimmun"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32833f1075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:00:37Z","timestamp":1620946837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201011000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32833f1075","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}